Tag: research
-
Absence of protein halts the growth of high-grade gliomas
Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas
-
Barcoding brain tumours
Researchers have barcoded cancer cells to learn more about growth patterns in hopes of developing more targeted treatments.
-
Nanoswimmers could be used to transport drugs past the blood brain barrier
Researchers have developed ‘nanoswimmers’ that cross the blood brain barrier highly efficiently.
-
New article explains why long-term survivors of childhood cancers develop meningiomas
In a new article for Nature Communication, scientists Gelareh Zadeh and Ken Aldape explain that radiation given during childhood cancer treatments causes DNA to rearrange. This rearrangement of DNA can then lead to menigiomas.
-
The Samantha Dickson Brain Cancer Unit discover brain mechanism that could target future therapies
The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body
-
Researchers find that ultrasound may help get drugs across the blood-brain barrier
This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands
-
Call for routine DNA test to be offered to all cancer patients
The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS
-
Researchers develop a probe that helps detect cancers cells with almost 100% accuracy
A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team
-
Scientists have discovered that a lack of ‘editing’ could be driving the most aggressive brain tumours
A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing
-
Researchers from the University of Ohio have found changes in blood that are detectable five years before the diagnosis of brain cancer
A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise
-
Scientists discover enzyme that supports brain tumour growth
Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments
-
We are co-funding Marie Curie’s call to address gaps in palliative and end of life care research
The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention
-
Encouraging results for new clinical approach to glioblastoma treatments
Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.
-
Pioneering research reveals new genetic errors that lead to an inherited risk of developing glioma
Scientists from The Institute of Cancer Research (ICR) have discovered 13 new genetic errors related with an increased risk of developing glioma in one of the largest ever studies of this devastating disease
-
Convection enhanced delivery of a water insoluble drug shows early promise in targeting high grade brain tumours
Findings from a study published in the International Journal of Nanomedicine have shown for the first time that the drug Panobinostat can be encapsulated in a water soluble molecule and delivered to a brain tumour to destroy high grade glioma cells.
-
King’s College Hospital trials Virtual Reality MRI scanner app to help patients
Researcher and clinicians at King’s College Hospital in London are trialling a Virtual Reality (VR) app to help children due to undergo an MRI (magnetic resonance imaging).
-
New research shows benefits of precision medicine in treating brain tumours in children
In the largest study of its kind, researchers found that advanced precision medicine has beneficial applications for treating childhood brain tumours.
-
Cannabis-derived medication shows promise in Phase 2 clinical study
Earlier this week, positive results were released from a clinical study testing a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) as a treatment in recurrent glioblastoma (GBM) patients in the UK.
-
Revolutionary new smart-needle could transform neurosurgery
Researchers at the University of Adelaide have developed a novel piece of technology that acts as a tiny flashlight, allowing surgeons to see into the brain. This machinery could transform neurosurgery for both patients and doctors.
-
Scientists find unlikely ally in Salmonella to target brain tumour cells
The cause behind millions of cases of food poisoning has been surprisingly effective in crossing the blood brain barrier to reach tumour sites. Researchers at Duke University genetically modified the bacteria Salmonella to enable it to seek out and attack glioblastoma tumour cells in animal models.
-
Targeting DNA repair protein for the treatment of glioblastoma
Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).
-
Exploiting metabolic pathways used by glioblastoma cells to halt tumour growth
A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.
-
We are hosting the biobanking workshop initiative in London today
The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.
-
Canadian researchers discover cell subgroups in treatment of paediatric ATRT brain cancer
Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).